L. Ebony Boulware, MD, MPH, Misty U. Troll, MPH, Bernard G

Slides:



Advertisements
Similar presentations
Renal Function Testing
Advertisements

KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD  Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,
Diagnosis and Treatment of Hyponatremia
Peritoneal dialysis American Journal of Kidney Diseases
Evaluation of Polyuria: The Roles of Solute Loading and Water Diuresis
Gregory L. Hundemer, MD, MPH, Andrew Z. Fenves, MD, Kristy M
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N
Association of Physical Activity and Renal Function in Subjects With and Without Metabolic Syndrome: A Review of the Third National Health and Nutrition.
Edmund J. Bini, MD, MPH, Aditi Kinkhabwala, MD, David S. Goldfarb, MD 
Amir Said Alizadeh Naderi, MD, Biff F. Palmer, MD 
A Decade After the KDOQI CKD Guidelines
World Kidney Day 2014: CKD and the Aging Population
Impact of Comorbidities on Mortality in Managed Care Patients With CKD
Awareness and Knowledge of Clinical Practice Guidelines for CKD Among Internal Medicine Residents: A National Online Survey  Varun Agrawal, MD, Amit K.
Evaluation of the Potential Living Kidney Donor
Focusing on Health Literacy Might Help Us Cross the Quality Chasm
Daniel E. Weiner, MD, MS  American Journal of Kidney Diseases 
Salt and Hypertension American Journal of Kidney Diseases
Guidelines for the Older Adult With CKD
Karl D. Nolph, MD, American Journal of Kidney Diseases
Lifetime Incidence of CKD Stages 3-5 in the United States
Cerebrovascular Disease Incidence, Characteristics, and Outcomes in Patients Initiating Dialysis: The Choices for Healthy Outcomes in Caring for ESRD.
Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S
Hypomagnesemia in a Patient With an Eating Disorder
Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road  Eduardo Lacson, MD, MPH, Franklin Maddux, MD 
Navdeep Tangri, MD, FRCPC, Daniel E. Weiner, MD, MS 
David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD 
Factors Influencing Route of Administration for Epoetin Treatment Among Hemodialysis Patients in the United States  Mae Thamer, PhD, Yi Zhang, DDS, MS,
Julie A. Wright Nunes, MD, MPH, Kerri L
The Map Is Not the Territory—Mapping Out the Course and Cost of CKD
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Elevated Fibroblast Growth Factor 23 in a Patient With Metastatic Prostate Cancer and Hypophosphatemia  Casey L. Cotant, MD, Panduranga S. Rao, MD, DNB,
A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico
CPR 1.2.: Evaluation of Anemia in CKD
Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP) 
Beef Tea, Vitality, Creatinine, and the Estimated GFR
American Journal of Kidney Diseases
Quiz Page April 2008 American Journal of Kidney Diseases
Study Designs in Patient-Oriented Research
Drug Dose Adjustments in Patients With Renal Impairment
Daniel T. Lackland, DrPH, David J.P. Barker, MD, PhD 
Erratum American Journal of Kidney Diseases
Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS 
Quiz Page August 2007 American Journal of Kidney Diseases
Risk for Incident Renal Dialysis in a Managed Care Population
Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies  Charuhas V. Thakar, MD  American Journal.
Arnold S. Relman, MD, American Journal of Kidney Diseases
Lesley A. Stevens, MD, MS, Josef Coresh, MD, PhD, Andrew S. Levey, MD 
Trial Quality in Nephrology: How Are We Measuring Up?
Removal of Dabigatran by Hemodialysis
Making Music American Journal of Kidney Diseases
Differences in Blood Transfusion Trends Between US and UK Centers
Erratum American Journal of Kidney Diseases
Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES),   Madhav V. Rao,
August Heidland, MD, Udo Bahner, MD, Spiros Vamvakas, MD 
Achieving Fairness in Access to Kidney Transplant: A Work in Progress
Five years is a long time, especially if you're a dean
Arteriovenous fistula creation: should US nephrologists get involved?
James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD 
Supportive care for patients with renal disease: Time for action
This Month in AJKD American Journal of Kidney Diseases
Quiz Page Answers July 2006 American Journal of Kidney Diseases
Dialysis Research and N-of-1 Trials: Made for Each Other?
Quiz Page January 2010 American Journal of Kidney Diseases
Serum Leptin and Epoetin Sensitivity
Clinical Practice Recommendations For Peritoneal Dialysis Adequacy
A Decade After the KDOQI CKD Guidelines: Impact on the National Kidney Foundation's Kidney Early Evaluation Program (KEEP)  Adam Whaley-Connell, DO, MSPH 
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Quiz page December 2003 American Journal of Kidney Diseases
Presentation transcript:

Identification and Referral of Patients With Progressive CKD: A National Study  L. Ebony Boulware, MD, MPH, Misty U. Troll, MPH, Bernard G. Jaar, MD, MPH, Donna I. Myers, MD, Neil R. Powe, MD, MPH, MBA  American Journal of Kidney Diseases  Volume 48, Issue 2, Pages 192-204 (August 2006) DOI: 10.1053/j.ajkd.2006.04.073 Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 1 Correct identification of CKD and recommendations for referral by physician specialty. *Adjusted for years in practice, practice setting, percentage of clinical time, census region, and patient race and comorbid conditions. **Adjusted for correct identification of stages 3 to 4 CKD, years in practice, practice setting, percentage of clinical time, census region, and patient race and comorbid conditions. American Journal of Kidney Diseases 2006 48, 192-204DOI: (10.1053/j.ajkd.2006.04.073) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 2 Diagnostic studies recommended* by physicians for the evaluation of a hypothetical patient with progressive CKD. (A) Serological and hematologic studies, (B) immunologic and virological studies, and (C) urine and radiological studies. *Adjusted for patient race and comorbid conditions. †Complete blood count. ‡Magnetic resonance angiography. □ = Family practice physicians; ▧ = general internists; ■ = nephrologists. American Journal of Kidney Diseases 2006 48, 192-204DOI: (10.1053/j.ajkd.2006.04.073) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions